Share the Video:

Being a Psychedelic Therapist

PS2023KetamineMDMAPsilocybinPsychedelic Assisted TherapyResearchResources for Therapists

Norma Stevens

This session will explore important underlying assumptions of psychedelic assisted therapy and how they affect the role of the therapist. We will also discuss BEING a psychedelic therapist–how one enters the space with presence to facilitate the healing in another. The speaker will use her own experiences in psychedelic assisted therapy with research volunteers using MDMA, psilocybin and ketamine to illustrate key concepts.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Related Videos

PS2023KetamineMDMAPsilocybinPsychedelic Assisted TherapyPsychedelic ScienceResearch

Psychedelics as The Great Disrupters: Reconstructing the Future of Mental Healthcare

Dr. Ben Sessa will discuss similarities among MDMA, ketamine, and psilocybin in clinical settings, exploring their potential in treating trauma-based disorders and challenges in psychedelic medicalization.

Ben Sessa

PS2023IntegrationPsychedelic Assisted TherapyPsychedelic ScienceResearchResources for Therapists

The Legacy of Stanislav Grof

Stanislav Grof, a pioneer in psychedelic research, presents the Grof® Legacy Training on 'holotropic' states of consciousness, with colleagues from international psychedelic training programs.

Brigitte Grof, Stanislav Grof, Diane Haug, Javier Charme, Neil Hannon, Jay Dufrechou

PS2023MDMAMDMA-assisted therapyPsychedelic Assisted TherapyPTSDResearch

Pioneers of MDMA Therapy: Reflections on 20+ Years of MDMA Therapy and Research

MAPS completes Phase 3 study for MDMA-AT in PTSD treatment, marking historic milestone in psychedelic drug research. Safety and efficacy of MDMA-assisted therapy still under investigation.

Keren Tzarfaty, Michael Mithoefer, Julie Holland

PS2023MDMAPsychedelic Assisted TherapyPsychedelic ScienceResearch

Grounding Psychedelic Research in Memory for Advancing Psychedelic Drug Discovery

M.K.D. discusses how psychedelics impact memory formation, suggesting potential for harnessing plasticity. J.K. concludes on how understanding mnemonic effects can shape clinical use and drug design.

James Keim

PS2023DMTLSDMDMAPsilocybinPsychedelic ScienceResearch

A conversation with Amanda Feilding and Rick Doblin, Ph.D.

Amanda Feilding, Founder of the Beckley Foundation, drives the Psychedelic Renaissance with groundbreaking research programs at top institutions worldwide, including pioneering studies on psilocybin, LSD, MDMA, and DMT.

PS2023MDMAPsychedelic Assisted TherapyResearch

Unlocking the Healing Potential: A Conversation on Experiential Training in MDMA-Assisted Therapy with Payton Nyquvest and Rick Doblin

Payton Nyquvest and Rick Doblin discuss MDMA-Assisted Therapy's transformative potential for healing and mental health in an insightful panel discussion.

PS2023MDMAPolicy and AdvocacyPsychedelic Assisted TherapyPsychedelic SciencePublic BenefitResearch

Preview Scene from Prescription X: The Rick Doblin and MAPS Documentary (Work in Progress)

"Prescription X: The Rick Doblin Story" documents Dr. Rick Doblin's quest with MAPS to legalize MDMA and psychedelics for therapy, culminating in a revealing film by Nirvan and Dream Mullick.

Nirvan Mullick, Dream Mullick

PS2023MDMAPsychedelic Assisted TherapyResearch

Investigational MDMA-assisted therapy and eating disorder symptoms in a randomized placebo-controlled trial for severe PTSD

MDMA-assisted therapy (MDMA-AT) shows promise in treating PTSD and comorbid eating disorders. A study found significant reductions in eating disorder symptoms with MDMA-AT compared to placebo in severe PTSD patients.

Adele LaFrance, Timothy Brewerton

PS2023IntegrationPolicy and AdvocacyPsychedelic Assisted TherapyPsychedelic ScienceResearchResources for Therapists

Improving study design in trials using psychedelic-assisted therapies

Psychedelic research faces challenges balancing methodological rigor with preserving subjective experiences in clinical trials, aiming to avoid bias while capturing the full impact of psychedelics on participants.

Ingmar Gorman, Erika Dyck, Tehseen Noorani